The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases
[Display omitted]
Gespeichert in:
| Veröffentlicht in: | Kidney international 2022-10, Vol.102 (4), p.922-925 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 925 |
|---|---|
| container_issue | 4 |
| container_start_page | 922 |
| container_title | Kidney international |
| container_volume | 102 |
| creator | Cheng, Franco Wing Tak Fan, Min Wong, Carlos King Ho Ling Chui, Celine Sze Tsun Lai, Francisco Tsz Li, Xue Fai Wan, Eric Yuk Wai Tang, Sydney Chi Chan, Esther W. Kei Wong, Ian Chi |
| description | [Display omitted] |
| doi_str_mv | 10.1016/j.kint.2022.07.018 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9367175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S008525382200610X</els_id><sourcerecordid>2702485999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-47445e61ec2247d20189fd4f76c932557f6b6e510faab8cbbbdf5b1337917f843</originalsourceid><addsrcrecordid>eNp9kd1qGzEQhUVpaZy0L9ArXToXu9XParWCUkjdv0BIoLi5FVppFMuxpWS13uJ3yENXrkOhN70ahvnOGWYOQu8oqSmh7ft1fR_iWDPCWE1kTWj3As2oYLyiUoiXaEZIJyomeHeCTnNek9IrTl6jEy5U20jVzdDTcgUYvAc7hgki5IxNdDgbD-MeJ4-3P64v8PzT9ZK2rGfnf6YhmgNuRnB4vkhDiubW2HO8uLm9_FxRhSdjbShm2GxTvCu8C1NwO7PJ-FcYV9iuiiZYfB9chD12IYPJkN-gV74w8Pa5nqGfX78sF9-rq5tvl4uLq8o2nI1VI5tGQEvBMtZIx8rhyrvGy9YqzoSQvu1bEJR4Y_rO9n3vvOgp51JR6buGn6GPR9-HXb8FZyGOg9nohyFszbDXyQT97ySGlb5Lk1a8leW3xWD-bDCkxx3kUW9DtrDZmAhplzWThDWdUEoVlB1RO6ScB_B_11CiDzHqtT7EqA8xaiJ1uaaIPhxFUL4wBRh0tgGiBReGkpR2KfxP_hvUkaWM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2702485999</pqid></control><display><type>article</type><title>The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases</title><source>Alma/SFX Local Collection</source><creator>Cheng, Franco Wing Tak ; Fan, Min ; Wong, Carlos King Ho ; Ling Chui, Celine Sze ; Tsun Lai, Francisco Tsz ; Li, Xue ; Fai Wan, Eric Yuk ; Wai Tang, Sydney Chi ; Chan, Esther W. ; Kei Wong, Ian Chi</creator><creatorcontrib>Cheng, Franco Wing Tak ; Fan, Min ; Wong, Carlos King Ho ; Ling Chui, Celine Sze ; Tsun Lai, Francisco Tsz ; Li, Xue ; Fai Wan, Eric Yuk ; Wai Tang, Sydney Chi ; Chan, Esther W. ; Kei Wong, Ian Chi</creatorcontrib><description>[Display omitted]</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1016/j.kint.2022.07.018</identifier><identifier>PMID: 35964798</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Research Letter</subject><ispartof>Kidney international, 2022-10, Vol.102 (4), p.922-925</ispartof><rights>2022</rights><rights>2022 Published by Elsevier, Inc., on behalf of the International Society of Nephrology. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-47445e61ec2247d20189fd4f76c932557f6b6e510faab8cbbbdf5b1337917f843</citedby><cites>FETCH-LOGICAL-c432t-47445e61ec2247d20189fd4f76c932557f6b6e510faab8cbbbdf5b1337917f843</cites><orcidid>0000-0002-6895-6071 ; 0000-0001-7818-1575</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,27931,27932</link.rule.ids></links><search><creatorcontrib>Cheng, Franco Wing Tak</creatorcontrib><creatorcontrib>Fan, Min</creatorcontrib><creatorcontrib>Wong, Carlos King Ho</creatorcontrib><creatorcontrib>Ling Chui, Celine Sze</creatorcontrib><creatorcontrib>Tsun Lai, Francisco Tsz</creatorcontrib><creatorcontrib>Li, Xue</creatorcontrib><creatorcontrib>Fai Wan, Eric Yuk</creatorcontrib><creatorcontrib>Wai Tang, Sydney Chi</creatorcontrib><creatorcontrib>Chan, Esther W.</creatorcontrib><creatorcontrib>Kei Wong, Ian Chi</creatorcontrib><title>The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases</title><title>Kidney international</title><description>[Display omitted]</description><subject>Research Letter</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kd1qGzEQhUVpaZy0L9ArXToXu9XParWCUkjdv0BIoLi5FVppFMuxpWS13uJ3yENXrkOhN70ahvnOGWYOQu8oqSmh7ft1fR_iWDPCWE1kTWj3As2oYLyiUoiXaEZIJyomeHeCTnNek9IrTl6jEy5U20jVzdDTcgUYvAc7hgki5IxNdDgbD-MeJ4-3P64v8PzT9ZK2rGfnf6YhmgNuRnB4vkhDiubW2HO8uLm9_FxRhSdjbShm2GxTvCu8C1NwO7PJ-FcYV9iuiiZYfB9chD12IYPJkN-gV74w8Pa5nqGfX78sF9-rq5tvl4uLq8o2nI1VI5tGQEvBMtZIx8rhyrvGy9YqzoSQvu1bEJR4Y_rO9n3vvOgp51JR6buGn6GPR9-HXb8FZyGOg9nohyFszbDXyQT97ySGlb5Lk1a8leW3xWD-bDCkxx3kUW9DtrDZmAhplzWThDWdUEoVlB1RO6ScB_B_11CiDzHqtT7EqA8xaiJ1uaaIPhxFUL4wBRh0tgGiBReGkpR2KfxP_hvUkaWM</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Cheng, Franco Wing Tak</creator><creator>Fan, Min</creator><creator>Wong, Carlos King Ho</creator><creator>Ling Chui, Celine Sze</creator><creator>Tsun Lai, Francisco Tsz</creator><creator>Li, Xue</creator><creator>Fai Wan, Eric Yuk</creator><creator>Wai Tang, Sydney Chi</creator><creator>Chan, Esther W.</creator><creator>Kei Wong, Ian Chi</creator><general>Elsevier Inc</general><general>Published by Elsevier, Inc., on behalf of the International Society of Nephrology</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6895-6071</orcidid><orcidid>https://orcid.org/0000-0001-7818-1575</orcidid></search><sort><creationdate>20221001</creationdate><title>The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases</title><author>Cheng, Franco Wing Tak ; Fan, Min ; Wong, Carlos King Ho ; Ling Chui, Celine Sze ; Tsun Lai, Francisco Tsz ; Li, Xue ; Fai Wan, Eric Yuk ; Wai Tang, Sydney Chi ; Chan, Esther W. ; Kei Wong, Ian Chi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-47445e61ec2247d20189fd4f76c932557f6b6e510faab8cbbbdf5b1337917f843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Research Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheng, Franco Wing Tak</creatorcontrib><creatorcontrib>Fan, Min</creatorcontrib><creatorcontrib>Wong, Carlos King Ho</creatorcontrib><creatorcontrib>Ling Chui, Celine Sze</creatorcontrib><creatorcontrib>Tsun Lai, Francisco Tsz</creatorcontrib><creatorcontrib>Li, Xue</creatorcontrib><creatorcontrib>Fai Wan, Eric Yuk</creatorcontrib><creatorcontrib>Wai Tang, Sydney Chi</creatorcontrib><creatorcontrib>Chan, Esther W.</creatorcontrib><creatorcontrib>Kei Wong, Ian Chi</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheng, Franco Wing Tak</au><au>Fan, Min</au><au>Wong, Carlos King Ho</au><au>Ling Chui, Celine Sze</au><au>Tsun Lai, Francisco Tsz</au><au>Li, Xue</au><au>Fai Wan, Eric Yuk</au><au>Wai Tang, Sydney Chi</au><au>Chan, Esther W.</au><au>Kei Wong, Ian Chi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases</atitle><jtitle>Kidney international</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>102</volume><issue>4</issue><spage>922</spage><epage>925</epage><pages>922-925</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><abstract>[Display omitted]</abstract><pub>Elsevier Inc</pub><pmid>35964798</pmid><doi>10.1016/j.kint.2022.07.018</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-6895-6071</orcidid><orcidid>https://orcid.org/0000-0001-7818-1575</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0085-2538 |
| ispartof | Kidney international, 2022-10, Vol.102 (4), p.922-925 |
| issn | 0085-2538 1523-1755 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9367175 |
| source | Alma/SFX Local Collection |
| subjects | Research Letter |
| title | The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T00%3A48%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effectiveness%20and%20safety%20of%20mRNA%20(BNT162b2)%20and%20inactivated%20(CoronaVac)%20COVID-19%20vaccines%20among%20individuals%20with%20chronic%20kidney%20diseases&rft.jtitle=Kidney%20international&rft.au=Cheng,%20Franco%20Wing%20Tak&rft.date=2022-10-01&rft.volume=102&rft.issue=4&rft.spage=922&rft.epage=925&rft.pages=922-925&rft.issn=0085-2538&rft.eissn=1523-1755&rft_id=info:doi/10.1016/j.kint.2022.07.018&rft_dat=%3Cproquest_pubme%3E2702485999%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2702485999&rft_id=info:pmid/35964798&rft_els_id=S008525382200610X&rfr_iscdi=true |